IDEAYA Biosciences, Inc. (IDYA) Profit Margins
Over the twelve months to 2026-06-30, IDEAYA Biosciences, Inc. (IDYA) had operating margin -92.7%, net margin -74.8%, free cash flow margin -48.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IDYAIDEAYA Biosciences, Inc.Follow IDYA — free
—
Price chart with a free account
- Market cap
- 3.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -180.9% | -179.9% | -122.7% | -574.9% | -4671.1% | -72.8% | -92.7% | |
| Net margin | -176.6% | -178.1% | -115.2% | -483.0% | -3921.1% | -52.0% | -74.8% | |
| FCF margin | 281.3% | -209.1% | -177.9% | -502.9% | -3592.0% | -33.6% | -48.6% |
USD billions · SEC XBRL
IDEAYA Biosciences, Inc. — questions
- What is IDEAYA Biosciences, Inc.'s operating margin?
- -92.7% over the twelve months to 2026-06-30.
- What is IDEAYA Biosciences, Inc.'s net profit margin?
- -74.8% over the twelve months to 2026-06-30.
Every figure on this page comes from IDEAYA Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.